search
Back to results

Error-enhancement for Arm Rehabilitation Post Stroke

Primary Purpose

Chronic Stroke

Status
Completed
Phase
Early Phase 1
Locations
Belgium
Study Type
Interventional
Intervention
DeXtreme training (error-enhancement)
Sponsored by
Universitaire Ziekenhuizen KU Leuven
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Stroke focused on measuring upper limb, neurorehabilitation, error-enhancement, robotic treatment

Eligibility Criteria

undefined - 85 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
  2. First stroke, confirmed by neurologist based on clinical and/or imaging findings
  3. Ischemic/hemorrhagic stroke, at least more than six months ago
  4. Stroke affecting the dominant/non-dominant upper limb (unilateral weakness)
  5. Less than 85 years old
  6. Having a motor impairment yet no severe spasticity in the upper limb: be able to open and close the hand 5 times and be able to flex and extend the elbow 2 times but score less than 66 (maximum) on the Fugl-Meyer Assessment.

Exclusion Criteria:

  1. Having sensory aphasia (evaluated by item 9 of the National Institutes of Health Stroke Scale)
  2. Having apraxia (evaluated by the apraxia screen of TULIA)
  3. Having neglect (evaluated by the Star Cancellation Test)
  4. Cognitive deficit with a score under 24 out of 30 on the Mini-mental State Examination
  5. Shoulder pain (yes/no)
  6. Providing no informed consent

Sites / Locations

  • UZ Leuven

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

DeXtreme (Error-enhacement)

Arm Description

Training (error-enhancement): 5 consecutive days, 1 hour per day

Outcomes

Primary Outcome Measures

Action research arm test
Evaluating UL functional ability, providing information whether improvement in impairment (FMA-UE) results in increased activity level. Internationally accepted outcome measure for stroke studies, and extensive experience available in the research group. min-max: 0-57 (higher = better)
Fugl-Meyer motor assessment upper extremity
Evaluating UL motor impairment (shoulder, elbow, wrist, hand and fingers), ability to measure restoration of function due to improved quality of movement. Internationally accepted outcome measure for stroke studies, and extensive experience available in the research group. min-max: 0-66 (higher = better)
Kinarm: visually guided reaching task
Assessment of motor function using a 4-target centre-out reaching task on the Kinarm End-Point Lab.
DeXtreme: reaching task - Market stand
Assessment of motor function using reaching tasks on the DeXtreme robot (range of motion and accuracy).
DeXtreme: reaching task - Alchemist
Assessment of motor function using reaching tasks on the DeXtreme robot (stability and smoothness).

Secondary Outcome Measures

Visual analogue scale (VAS) - Pain
A measurement instrument that tries to measure a characteristic that is believed to range across a continuum of values and cannot easily be directly measured. In this case, it is used to determine the pain in the shoulder region. min-max: 0-100 (higher = worse)
Motor assessment scale - tonus
A single item of the MAS, general tonus, intended to provide an estimate of muscle tone of the arm/hand on the affected side. Min-max: 0-6 (4 = normal tone, > 4 = hyper tone; < 4 = hypo tone)
Kinarm: sensory processing task
Newly-developed task on the Kinarm End-Point Lab used to assess passive and active sensory processing.
Motor assessment scale - upper limb
A performance-based scale to assess everyday upper limb motor functions, based on a task-oriented approach to evaluation that assesses performance of functional tasks. min-max: 0 - 18 (higher = better)
Stroke impact scale - Hand
Evaluating perceived function and quality of life with stroke: perceived hand function, scoring difficulty of five manual activities using the most affected hand. Experience present in the research group. min-max: 0-100 (higher = better)
Motor Activity Log - 14 items
Evaluating the amount of use and the quality of the movement of the more-affected arm during functional activities, through a structured interview (patient reported outcome). min-max: 0-5 (higher = better)
Kinarm: arm position matching task
Assessment of limb position sense using a 9-target mirror-matching task on the Kinarm Exoskeleton Lab.

Full Information

First Posted
December 24, 2021
Last Updated
March 30, 2023
Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
KU Leuven, Bioxtreme Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT05229185
Brief Title
Error-enhancement for Arm Rehabilitation Post Stroke
Official Title
Error-enhancement as Basis for Novel Upper Limb Rehabilitation in the Chronic Phase After Stroke: a 5-day Pre-post Intervention Study.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
January 25, 2022 (Actual)
Primary Completion Date
November 23, 2022 (Actual)
Study Completion Date
November 23, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
KU Leuven, Bioxtreme Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Even in a chronic phase after stroke, most patients have difficulty moving the affected arm, resulting in limitations in simple tasks in daily living, most frequently limiting reaching task. In the chronic phase, significant improvements are usually no longer observed. Nevertheless, even these patients can still improve their functional abilities due to exercise-dependent plasticity. A new device was developed, the deXtreme robot, a rehabilitation device that offers error-enhancement approach during three-dimensional movements. The goal error-enhancement is to elicit better accuracy, stability, fluidity and range of motion during reaching. games are projected on a screen, requiring 3D active reaching movements. The duration of the study for a single participant will be 7 consecutive working days, including 1 day of pre-intervention assessment, 5 days of training and 1 day of post-intervention assessment. The overall aim of this project is to gain knowledge into the potential of error-enhancement robot training in patients with upper limb impairments in the chronic phase after stroke. Hypothesizing that the 5-day training will have a positive effect on both the robotic and clinical outcome measures.
Detailed Description
The overall aim of this study is to gain knowledge into the potential of error-enhancement robot training in patients with upper limb impairments in the chronic phase after stroke. Error-enhancement is characterized as unexpected external perturbation forces acting upon the upper limb during a reaching movement, causing the upper limb to deflect from the reaching pathway, and this results in errors. If one allows for repetitive reaching performance with the same systematic perturbation forces, then a decrease in errors and improvement in movement performance is expected. The robot used for the training, the DeXtreme, is a CE marked rehabilitation device that offers this error-enhancement approach during three-dimensional movements. The pilot study has a pre-post intervention design, recruiting 20 patients in the chronic phase after stroke. Error-enhancement treatment will be provided on day 2 to 6, i.e., for 5 consecutive days and will consist of facilitation of accuracy, range of movement, stability, and smoothness. Algorithms provide progression in terms of accuracy, range of movement, stability and smoothness, depending upon the performance of the patient. The treatment will start with the installation of the patient and a warming up, followed by a first block of DeXtreme training. Then a short break is given followed by a short conventional therapy session. The content of the conventional therapy will involve active relaxation, focusing on stretching and (auto-)mobilisation. Afterwards, a second block of training with the DeXtreme follows, and it finishes with a cooling down. A therapist trained by the company will provide all assessment and training sessions. Training with the DeXtreme is additional to the conventional therapy the patient receives. Therefore, a diary of their conventional therapy sessions will be kept, and the content will be reviewed with the patient. Advancements in upper limb motor function and activity will be evaluated through a triad of measurements including clinical and patient-reported outcomes, error-enhancement variables, and objective quantification of uni- and bimanual sensorimotor function by making use of the KINARM robotic manipulandum. These tests and questionnaires are administered on day 1 and day 7. The aim of the study is to investigate whether patients with upper limb impairments in a chronic phase after stroke clinical and meaningful benefits from 5 hours DeXtreme training. In addition, it is examined whether improvements in the upper limb outcome is the result of restitution or compensation in the upper limb function. In order to evaluate whether a randomized controlled trial is useful, the investigators will analyse the outcomes of our study twofold. (1) At group level, the investigators will calculate mean and standard deviation or median and interquartile range (based on whether data is normally distributed or not) and evaluate whether pre- to post-intervention scores for clinical, deXtreme and objective outcomes are significantly improved by means of Wilcoxon signed rank test (nonparametric), at a 0,05 significance level. Each p-value will be interpreted in a descriptive manner. (2) At patient level, the investigators will evaluate how many patients (%) achieve a clinically significant improvement based on the therapy provided. To see if the improvement might be explained by restitution or compensation, the association between the scores of the MAL-14 and the visually guided reaching task of the KINARM will be explored by Spearman correlations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Stroke
Keywords
upper limb, neurorehabilitation, error-enhancement, robotic treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Model Description
This study has a pre-post intervention design, recruiting 20 patients in the chronic phase after stroke. Pre- and post-intervention assessments are administered on day 1 and 7.The 5 days in between, all patients receive the same training with the robot, there is no control group.
Masking
None (Open Label)
Allocation
N/A
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DeXtreme (Error-enhacement)
Arm Type
Experimental
Arm Description
Training (error-enhancement): 5 consecutive days, 1 hour per day
Intervention Type
Device
Intervention Name(s)
DeXtreme training (error-enhancement)
Intervention Description
15-20 min DeXtreme - 15 min conventional therapy - 15-20 min DeXtreme
Primary Outcome Measure Information:
Title
Action research arm test
Description
Evaluating UL functional ability, providing information whether improvement in impairment (FMA-UE) results in increased activity level. Internationally accepted outcome measure for stroke studies, and extensive experience available in the research group. min-max: 0-57 (higher = better)
Time Frame
day 1(pre) - day 7 (post)
Title
Fugl-Meyer motor assessment upper extremity
Description
Evaluating UL motor impairment (shoulder, elbow, wrist, hand and fingers), ability to measure restoration of function due to improved quality of movement. Internationally accepted outcome measure for stroke studies, and extensive experience available in the research group. min-max: 0-66 (higher = better)
Time Frame
day 1(pre) - day 7 (post)
Title
Kinarm: visually guided reaching task
Description
Assessment of motor function using a 4-target centre-out reaching task on the Kinarm End-Point Lab.
Time Frame
day 1(pre) - day 7 (post)
Title
DeXtreme: reaching task - Market stand
Description
Assessment of motor function using reaching tasks on the DeXtreme robot (range of motion and accuracy).
Time Frame
day 1(pre) - day 7 (post)
Title
DeXtreme: reaching task - Alchemist
Description
Assessment of motor function using reaching tasks on the DeXtreme robot (stability and smoothness).
Time Frame
day 1(pre) - day 7 (post)
Secondary Outcome Measure Information:
Title
Visual analogue scale (VAS) - Pain
Description
A measurement instrument that tries to measure a characteristic that is believed to range across a continuum of values and cannot easily be directly measured. In this case, it is used to determine the pain in the shoulder region. min-max: 0-100 (higher = worse)
Time Frame
day 1(pre) - day 7 (post); after treatment (day 2-5)
Title
Motor assessment scale - tonus
Description
A single item of the MAS, general tonus, intended to provide an estimate of muscle tone of the arm/hand on the affected side. Min-max: 0-6 (4 = normal tone, > 4 = hyper tone; < 4 = hypo tone)
Time Frame
day 1(pre) - day 7 (post); after treatment (day 2-5)
Title
Kinarm: sensory processing task
Description
Newly-developed task on the Kinarm End-Point Lab used to assess passive and active sensory processing.
Time Frame
day 1(pre) - day 7 (post)
Title
Motor assessment scale - upper limb
Description
A performance-based scale to assess everyday upper limb motor functions, based on a task-oriented approach to evaluation that assesses performance of functional tasks. min-max: 0 - 18 (higher = better)
Time Frame
day 1(pre) - day 7 (post)
Title
Stroke impact scale - Hand
Description
Evaluating perceived function and quality of life with stroke: perceived hand function, scoring difficulty of five manual activities using the most affected hand. Experience present in the research group. min-max: 0-100 (higher = better)
Time Frame
day 1(pre) - day 7 (post)
Title
Motor Activity Log - 14 items
Description
Evaluating the amount of use and the quality of the movement of the more-affected arm during functional activities, through a structured interview (patient reported outcome). min-max: 0-5 (higher = better)
Time Frame
day 1(pre) - day 7 (post)
Title
Kinarm: arm position matching task
Description
Assessment of limb position sense using a 9-target mirror-matching task on the Kinarm Exoskeleton Lab.
Time Frame
day 1(pre) - day 7 (post)

10. Eligibility

Sex
All
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures First stroke, confirmed by neurologist based on clinical and/or imaging findings Ischemic/hemorrhagic stroke, at least more than six months ago Stroke affecting the dominant/non-dominant upper limb (unilateral weakness) Less than 85 years old Having a motor impairment yet no severe spasticity in the upper limb: be able to open and close the hand 5 times and be able to flex and extend the elbow 2 times but score less than 66 (maximum) on the Fugl-Meyer Assessment. Exclusion Criteria: Having sensory aphasia (evaluated by item 9 of the National Institutes of Health Stroke Scale) Having apraxia (evaluated by the apraxia screen of TULIA) Having neglect (evaluated by the Star Cancellation Test) Cognitive deficit with a score under 24 out of 30 on the Mini-mental State Examination Shoulder pain (yes/no) Providing no informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Geert Verheyden
Organizational Affiliation
KU Leuven
Official's Role
Principal Investigator
Facility Information:
Facility Name
UZ Leuven
City
Leuven
State/Province
Vlaams-Brabant
ZIP/Postal Code
3000
Country
Belgium

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
31818684
Citation
Kim RK, Kang N. Bimanual Coordination Functions between Paretic and Nonparetic Arms: A Systematic Review and Meta-analysis. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104544. doi: 10.1016/j.jstrokecerebrovasdis.2019.104544. Epub 2019 Dec 6.
Results Reference
background
PubMed Identifier
30770457
Citation
Ward NS, Brander F, Kelly K. Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme. J Neurol Neurosurg Psychiatry. 2019 May;90(5):498-506. doi: 10.1136/jnnp-2018-319954. Epub 2019 Feb 15.
Results Reference
background
PubMed Identifier
29564773
Citation
Israely S, Leisman G, Carmeli E. Improvement in Hand Trajectory of Reaching Movements by Error-Augmentation. Adv Exp Med Biol. 2018;1070:71-84. doi: 10.1007/5584_2018_151.
Results Reference
background
PubMed Identifier
21609832
Citation
Huang VS, Haith A, Mazzoni P, Krakauer JW. Rethinking motor learning and savings in adaptation paradigms: model-free memory for successful actions combines with internal models. Neuron. 2011 May 26;70(4):787-801. doi: 10.1016/j.neuron.2011.04.012.
Results Reference
background
Available IPD and Supporting Information:
Available IPD/Information Type
Study Protocol
Available IPD/Information URL
https://kuleuven-my.sharepoint.com/:b:/g/personal/marjan_coremans_kuleuven_be/EVK-M1j5Ax9GjNEFv1mk_NMB-YFjnBVTAR1V4FTJx5sc1w?e=3HuBGr
Available IPD/Information Comments
Find the document using the link above.
Available IPD/Information Type
Informed Consent Form
Available IPD/Information URL
https://kuleuven-my.sharepoint.com/:b:/g/personal/marjan_coremans_kuleuven_be/EVB9pKxi-X5Mk5YjAqkTgoQByjOoqnPA8ccpmHqFrX-WMg?e=zGCWri
Available IPD/Information Comments
Find the document using the link above.

Learn more about this trial

Error-enhancement for Arm Rehabilitation Post Stroke

We'll reach out to this number within 24 hrs